The purpose of this study was to evaluate whether use of combined radiofrequency ablation ( RFA ) and percutaneous iodine-125 ( ( 125 ) I ) seed implantation results in better progression-free survival compared with the use of RFA alone in patients with hepatocellular carcinoma .